YMAB CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages Y-mAbs Therapeutics (YMAB) Investors with Significant ...
SAN FRANCISCO, CA / ACCESSWIRE / January 27, 2023 / Hagens Berman urges Y-mAbs Therapeutics, Inc. YMAB investors who suffered significant losses to submit your losses now. Class Period: Oct. 6, 2020 - Oct. 28, 2022 Lead Plaintiff Deadline: Mar. 20, 2023 …